Skip to main content
. 2021 Sep 14;27(34):5700–5714. doi: 10.3748/wjg.v27.i34.5700

Table 1.

Key Features of pancreatic cyst guidelines

Specifics of Guidelines
2015 AGA
2017 Fukuoka
2017 ACG
2017 ACR
2018 European Study Group
Patient population Incidental pancreatic cysts Suspected MCN and IPMN All pancreatic cysts Incidental pancreatic cysts All pancreatic cysts
Threshold for EUS and/or surgery At least 2 risk factors 1 risk factor 1 risk factor 1 risk factor 1 risk factor
Surveillance recommendations in unresected cysts MRI in 1 year, then every 2 yr Surveillance based on cyst size Surveillance based on cyst size Surveillance based on cyst size and age Surveillance based on cyst size and diagnosis
Stopping surveillance (1) After 5 yr of stability without development of high-risk features; (2) Surgically unfit; and (3) Select resected cysts including BD-IPMN with no, low or moderate-grade dysplasia (1) Surgically unfit; and (2) Following resection of serous cystadenoma and MCN without invasive cancer (1) Surgically unfit; (2) Following resection of serous cystadenoma and MCN without invasive cancer; and (3) Individualize approach to patients > 75 (1) 9-10 yr and stop at age 80; and (2) For cysts discovered > age 80, limited surveillance for 4 yr only if stable Surgically unfit

AGA: American Gastroenterological Association; ACG: American College of Gastroenterology; EUS: Endoscopic ultrasound; MRI: Magnetic resonance imaging; MCN: Mucinous cystic neoplasm; IPMN: Intraductal papillary mucinous neoplasm; BD-IPMN: Branch duct-intraductal papillary mucinous neoplasm.